BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 28584890)

  • 1. Survival benefit of "D2-plus" gastrectomy in gastric cancer patients with duodenal invasion.
    Kumagai K; Sano T; Hiki N; Nunobe S; Tsujiura M; Ida S; Ohashi M; Yamaguchi T
    Gastric Cancer; 2018 Mar; 21(2):296-302. PubMed ID: 28584890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of D2-plus radical resection for gastric cancer with pyloric invasion.
    Xu ZY; Hu C; Chen S; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    BMC Surg; 2019 Nov; 19(1):172. PubMed ID: 31747885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of D2 and D2 plus radical surgery for advanced distal gastric cancer: a randomized controlled study.
    Yu P; Du Y; Xu Z; Huang L; Cheng X
    World J Surg Oncol; 2019 Feb; 17(1):28. PubMed ID: 30728027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis.
    Sun W; Deng J; Zhang N; Liu H; Liu J; Gu P; Du Y; Wu Z; He W; Wang P; Liang H
    Chin J Cancer Res; 2020 Feb; 32(1):51-61. PubMed ID: 32194305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved survival after adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for advanced distal gastric cancer.
    Eom BW; Joo J; Kim YW; Reim D; Park JY; Yoon HM; Ryu KW; Lee JY; Kook MC
    Surgery; 2014 Mar; 155(3):408-16. PubMed ID: 24287148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival prognosis and clinicopathological features of the lymph nodes along the left gastric artery in gastric cancer: implications for D2 lymphadenectomy.
    Chen JH; Cai SR; Zhai ET; Chen SL; Wu KM; Song W; He YL
    Int J Clin Exp Pathol; 2015; 8(11):14365-73. PubMed ID: 26823752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it necessary to dissect the posterior lymph nodes along the splenic vessels during total gastrectomy with D2 lymphadenectomy for advanced gastric cancer?
    Lin JX; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M
    Eur J Surg Oncol; 2017 Dec; 43(12):2357-2365. PubMed ID: 29032923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics of gastric cancer with metastasis to the lymph node along the superior mesenteric vein (14v).
    Masuda TA; Sakaguchi Y; Toh Y; Aoki Y; Harimoto N; Taomoto J; Ikeda O; Ohga T; Adachi E; Okamura T
    Dig Surg; 2008; 25(5):351-8. PubMed ID: 18957850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical value of superior mesenteric vein (No.14v) lymph node dissection in D2 gastrectomy for locally advanced distal gastric cancer].
    Lu W; Zeng X; Li N; Liu H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1136-1141. PubMed ID: 30370512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Significance of Lymph Node Dissection Along the Upper-third-stomach in Patients With Lower-third Gastric Cancer.
    Saito R; Kawaguchi Y; Akaike H; Shiraishi K; Maruyama S; Shimizu H; Furuya S; Hosomura N; Amemiya H; Kawaida H; Sudo M; Inoue S; Kono H; Ichikawa D
    Anticancer Res; 2019 Mar; 39(3):1485-1489. PubMed ID: 30842186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is it worthy of adding dissection of the superior mesenteric vein lymph node (14v) to standard D2 gastrectomy for distal gastric cancers with No. 6 lymph node metastasis?
    Zhang J; Zou S; Luo R; Zhu Z; Wang Z; Xu H; Huang B
    Clin Transl Oncol; 2019 Dec; 21(12):1699-1706. PubMed ID: 30977046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and prognostic impact of prophylactic laparoscopic superior mesenteric vein (No. 14v) lymph node dissection for lower-third gastric cancer: a propensity score-matched case-control study.
    Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Cao LL; Lin M; Tu RH; Huang ZN; Lin JL; Huang CM
    Surg Endosc; 2018 Mar; 32(3):1495-1505. PubMed ID: 28916893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of skeletonization of the hepatoduodenal ligament for the lower third gastric cancer by propensity score analysis.
    Wei ZW; Xia GK; Wu Y; Schwarz RE; Smith DD; He YL; Zhang CH
    Hepatogastroenterology; 2013 Oct; 60(127):1789-96. PubMed ID: 24624453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis.
    Tsuburaya A; Mizusawa J; Tanaka Y; Fukushima N; Nashimoto A; Sasako M;
    Br J Surg; 2014 May; 101(6):653-60. PubMed ID: 24668391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach.
    Chen QY; Huang CM; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Yang XT
    Ann Surg Oncol; 2016 Mar; 23(3):951. PubMed ID: 26714942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective randomized controlled trial to compare laparoscopic distal gastrectomy (D2 lymphadenectomy plus complete mesogastrium excision, D2 + CME) with conventional D2 lymphadenectomy for locally advanced gastric adenocarcinoma: study protocol for a randomized controlled trial.
    Shen J; Cao B; Wang Y; Xiao A; Qin J; Wu J; Yan Q; Hu Y; Yang C; Cao Z; Hu J; Yin P; Xie D; Gong J
    Trials; 2018 Aug; 19(1):432. PubMed ID: 30092843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal extent of lymph node dissection for remnant advanced gastric carcinoma after distal gastrectomy: a retrospective analysis of more than 3000 patients from the nationwide registry of the Japanese Gastric Cancer Association.
    Katai H; Ishikawa T; Akazawa K; Fukagawa T; Isobe Y; Miyashiro I; Oda I; Tsujitani S; Ono H; Tanabe S; Nunobe S; Suzuki S; Kakeji Y;
    Gastric Cancer; 2020 Nov; 23(6):1091-1101. PubMed ID: 32419120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of spleen-preserving lymphadenectomy in total gastrectomy for gastric and esophagogastric junctional adenocarcinomas: A long-term retrospective propensity score match study from a high-volume institution in China.
    Liu K; Chen XZ; Zhang YC; Zhang WH; Chen XL; Sun LF; Yang K; Zhang B; Zhou ZG; Hu JK
    Surgery; 2021 Feb; 169(2):426-435. PubMed ID: 32950240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.
    Woo Y; Goldner B; Ituarte P; Lee B; Melstrom L; Son T; Noh SH; Fong Y; Hyung WJ
    J Am Coll Surg; 2017 Apr; 224(4):546-555. PubMed ID: 28017807
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility of No.8p lymphadenectomy for the patients with advanced gastric cancer].
    Ye Z; Zeng Y; Wei S; Wang Y; Lin Z; Lin Z; Chen X; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Oct; 21(10):1129-1135. PubMed ID: 30370511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.